Procalcitonin (PCT) is widely considered as a highly sensitive biomarker of bacterial infection, offering general and emergency surgeons a key tool in the management of surgical infections. A multidisciplinary task force of experts met in Bologna, Italy, on April 4, 2019, to clarify the key issues in the use of PCT across the surgical pathway. The panelists presented the statements developed for each of the main questions regarding the use of PCT across the surgical pathway. An agreement on the statements was reached by the Delphi method, and this document reports the executive summary of the final recommendations approved by the expert panel.
Sartelli, M., Ansaloni, L., Bartoletti, M., Catena, F., Cardi, M., Cortese, F., Di Marzo, F., Pea, F., Plebani, M., Rossolini, G. M., Sganga, G., Viaggi, B., Viale, P., The role of procalcitonin in reducing antibiotics across the surgical pathway, <<WORLD JOURNAL OF EMERGENCY SURGERY>>, 2021; 16 (1): 15-N/A. [doi:10.1186/s13017-021-00357-0] [http://hdl.handle.net/10807/179356]
The role of procalcitonin in reducing antibiotics across the surgical pathway
Cortese, Francesco;Pea, Federico;Sganga, Gabriele;
2021
Abstract
Procalcitonin (PCT) is widely considered as a highly sensitive biomarker of bacterial infection, offering general and emergency surgeons a key tool in the management of surgical infections. A multidisciplinary task force of experts met in Bologna, Italy, on April 4, 2019, to clarify the key issues in the use of PCT across the surgical pathway. The panelists presented the statements developed for each of the main questions regarding the use of PCT across the surgical pathway. An agreement on the statements was reached by the Delphi method, and this document reports the executive summary of the final recommendations approved by the expert panel.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
